97 related articles for article (PubMed ID: 22879065)
1. Purinergic signaling in glioma progression.
Braganhol E; Wink MR; Lenz G; Battastini AM
Adv Exp Med Biol; 2013; 986():81-102. PubMed ID: 22879065
[TBL] [Abstract][Full Text] [Related]
2. Purinergic Signaling in Glioma Progression.
Braganhol E; Wink MR; Lenz G; Battastini AMO
Adv Exp Med Biol; 2020; 1202():87-108. PubMed ID: 32034710
[TBL] [Abstract][Full Text] [Related]
3. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
4. Selective NTPDase2 expression modulates in vivo rat glioma growth.
Braganhol E; Morrone FB; Bernardi A; Huppes D; Meurer L; Edelweiss MI; Lenz G; Wink MR; Robson SC; Battastini AM
Cancer Sci; 2009 Aug; 100(8):1434-42. PubMed ID: 19558578
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model.
Braganhol E; Huppes D; Bernardi A; Wink MR; Lenz G; Battastini AM
Cell Tissue Res; 2009 Feb; 335(2):331-40. PubMed ID: 19023597
[TBL] [Abstract][Full Text] [Related]
6. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ATP-induced cell death in the GL261 mouse glioma.
Tamajusuku AS; Villodre ES; Paulus R; Coutinho-Silva R; Battasstini AM; Wink MR; Lenz G
J Cell Biochem; 2010 Apr; 109(5):983-91. PubMed ID: 20069573
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells.
Braganhol E; Kukulski F; Lévesque SA; Fausther M; Lavoie EG; Zanotto-Filho A; Bergamin LS; Pelletier J; Bahrami F; Ben Yebdri F; Fonseca Moreira JC; Battastini AM; Sévigny J
Biochim Biophys Acta; 2015 Jan; 1852(1):120-30. PubMed ID: 25445541
[TBL] [Abstract][Full Text] [Related]
9. P2Y
Morrone FB; Vargas P; Rockenbach L; Scheffel TB
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684726
[TBL] [Abstract][Full Text] [Related]
10. Adenosine signaling in glioma cells.
Ceruti S; Abbracchio MP
Adv Exp Med Biol; 2013; 986():13-30. PubMed ID: 22879062
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury.
Braganhol E; Zanin RF; Bernardi A; Bergamin LS; Cappellari AR; Campesato LF; Morrone FB; Campos MM; Calixto JB; Edelweiss MI; Wink MR; Sévigny J; Robson SC; Battastini AM
Purinergic Signal; 2012 Jun; 8(2):235-43. PubMed ID: 22038661
[TBL] [Abstract][Full Text] [Related]
12. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
[TBL] [Abstract][Full Text] [Related]
13. Increased resistance of glioma cell lines to extracellular ATP cytotoxicity.
Morrone FB; Horn AP; Stella J; Spiller F; Sarkis JJ; Salbego CG; Lenz G; Battastini AM
J Neurooncol; 2005 Jan; 71(2):135-40. PubMed ID: 15690128
[TBL] [Abstract][Full Text] [Related]
14. TGF beta signaling and its role in glioma pathogenesis.
Kaminska B; Kocyk M; Kijewska M
Adv Exp Med Biol; 2013; 986():171-87. PubMed ID: 22879069
[TBL] [Abstract][Full Text] [Related]
15. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
17. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signaling induces thrombospondin-1 expression in astrocytes.
Tran MD; Neary JT
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9321-6. PubMed ID: 16754856
[TBL] [Abstract][Full Text] [Related]
19. Calcium dependence of purinergic subtype P2Y₁ receptor modulation of C6 glioma cell migration.
Jantaratnotai N; McLarnon JG
Neurosci Lett; 2011 Jun; 497(2):80-4. PubMed ID: 21540076
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk in nucleotide signaling in glioma C6 cells.
Wypych D; Barańska J
Adv Exp Med Biol; 2013; 986():31-59. PubMed ID: 22879063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
